CA2084677A1 - Apo ai polypeptides, antibodies, and immunoassays - Google Patents

Apo ai polypeptides, antibodies, and immunoassays

Info

Publication number
CA2084677A1
CA2084677A1 CA002084677A CA2084677A CA2084677A1 CA 2084677 A1 CA2084677 A1 CA 2084677A1 CA 002084677 A CA002084677 A CA 002084677A CA 2084677 A CA2084677 A CA 2084677A CA 2084677 A1 CA2084677 A1 CA 2084677A1
Authority
CA
Canada
Prior art keywords
apo
antibodies
polypeptide
immunoassays
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002084677A
Other languages
French (fr)
Other versions
CA2084677C (en
Inventor
Linda K. Curtiss
Carole L. Banka
David J. Bonnet
Richard S. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2084677A1 publication Critical patent/CA2084677A1/en
Application granted granted Critical
Publication of CA2084677C publication Critical patent/CA2084677C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention describes an Apo AI polypeptide capable of immunologically mimicking an Apo AI epitope. The polypeptide is useful in diagnostic methods and systems for detecting Apo AI
in vascular fluid samples, and for preparation of anti-Apo AI antibodies. In addition, the polypeptide is useful in therapeutic methods for increasing esterified cholesterol in a hu-man patient.
CA002084677A 1990-06-07 1991-06-07 Apo ai polypeptides, antibodies, and immunoassays Expired - Fee Related CA2084677C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53476190A 1990-06-07 1990-06-07
US534,761 1990-06-07
PCT/US1991/004038 WO1991018619A1 (en) 1990-06-07 1991-06-07 Apo ai polypeptides, antibodies, and immunoassays

Publications (2)

Publication Number Publication Date
CA2084677A1 true CA2084677A1 (en) 1991-12-08
CA2084677C CA2084677C (en) 2003-11-04

Family

ID=24131429

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002084677A Expired - Fee Related CA2084677C (en) 1990-06-07 1991-06-07 Apo ai polypeptides, antibodies, and immunoassays

Country Status (6)

Country Link
EP (1) EP0500826A4 (en)
JP (1) JPH06508344A (en)
CA (1) CA2084677C (en)
IE (1) IE911922A1 (en)
PT (1) PT97914B (en)
WO (1) WO1991018619A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125678B2 (en) * 2001-11-23 2006-10-24 Nanogen, Inc. Protein biopolymer markers predictive of type II diabetes
LT2631248T (en) 2007-06-15 2018-04-25 Medigene Ag Treatment of tumors using specific anti-L1 antibody
NO335243B1 (en) 2008-01-08 2014-10-27 Isola As Cradle plate, as well as the application and method of laying a floor covering using such a cradle plate.
JP7023932B2 (en) * 2017-03-30 2022-02-22 シスメックス株式会社 Anti-ApoA1 antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055396A (en) * 1987-11-03 1991-10-08 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
KR900700884A (en) * 1988-03-29 1990-08-17 레이먼드 에이치. 칸 Diagnostic Methods and Diagnostic Systems for Quantifying Apo AI

Also Published As

Publication number Publication date
CA2084677C (en) 2003-11-04
EP0500826A4 (en) 1993-06-30
JPH06508344A (en) 1994-09-22
WO1991018619A1 (en) 1991-12-12
PT97914B (en) 1998-11-30
PT97914A (en) 1992-03-31
EP0500826A1 (en) 1992-09-02
IE911922A1 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
EP0344940A3 (en) Antibodies to human papillomavirus latent proteins, diagnostic systems and methods
AU2843889A (en) Antigen antibody conjugate
EP0416911A3 (en) Ultrasonic air-in-line detector self-test technique
AU2460988A (en) Simultaneous immunoassay for the determination of antigens and antibodies
AU3180393A (en) Improved sol capture immunoassay procedure
AU614363B2 (en) System for determining the angular spin position of an object
CA2078549A1 (en) Multiple sclerosis t-cell receptor
AU614612B2 (en) System for determining the angular spin position of an object
CA2084677A1 (en) Apo ai polypeptides, antibodies, and immunoassays
AU7444891A (en) New hiv p24 peptides, diagnostic antigens and discriminative immunoassay method
ZA895821B (en) Method for the microbiological preparation of human serum albumin and other heterologous proteins from a yeast
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
EP0311094A3 (en) Diagnostic agent and method for the determination of apolipoprotein b
CA2106563A1 (en) Cocaine derivatives and protein and polypeptide cocaine derivative conjugates and labels
AU4172189A (en) Heat bond tape for carpet seaming
GB2199038B (en) Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies
CA2080408A1 (en) Artificial standard and control sera, processes for the preparation thereof and the use thereof
AU3829189A (en) Detecting antigens or antibodies
CA2102115A1 (en) In vitro methods for determining in vivo thrombotic events
GB9211902D0 (en) Method of determining the allergenic response of a sample of mammalian blood to an antigen
AU2312288A (en) A rapid "cowside" immunoassay for milk progesterone
EP0364560A4 (en) Diagnostic methods and systems for quantifying apo ai
AU1424392A (en) The use of reference sera in immunoassays for detecting antibodies against mycobacteria
AU3706689A (en) Method for detection of antibodies or antigens in a test fluid

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed